Purpose To evaluate the role of circulating Epstein-Barr virus (EBV) DNA in lymphoma-
associated hemophagocytic lymphohistiocytosis (HLH). Methods We conducted a …

Background Hemophagocytic lymphohistiocytosis (HLH) associated with B-cell lymphoma is
a highly aggressive disease with unclear clinical features and has no standard treatment …

To determine whether the EBV genome content in serum or plasma reflects clinical features
and outcome in EBV-associated hemophagocytic lymphohistiocytosis (EBV-HLH), we …

Objective To investigate the outcomes, survival status, and the prognostic factors of Epstein-
Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) patients. Methods A …

PURPOSE: We sought to identify the clinical variables most critical to successful treatment of
Epstein-Barr virus (EBV)–associated hemophagocytic lymphohistiocytosis (HLH). PATIENTS …

Purpose To investigate clinical characteristics, management, and prognosis of Epstein-Barr
virus (EBV)-positive lymphoma-associated hemophagocytic syndrome (LAHS) patients in …

This study investigated the clinical characteristics of Hodgkin lymphoma-associated
hemophagocytic lymphohistiocytosis (HLH-HL). Clinical data of 8 patients with HLH-HL and …

Limited data are available about the underlying causes of hemophagocytic
lymphohistiocytosis (HLH) in adults. We collected and analyzed the data of 555 cases of …

Background Viruses may induce primary as well as secondary hemophagocytic
lymphohistiocytosis (HLH), but it may not be possible to discriminate between these two in …

BACKGROUND AND OBJECTIVES: Although immunochemotherapy has been reported to
be an effective initial treatment for patients with Epstein-Barr virus-associated …